<DOC>
	<DOCNO>NCT00561223</DOCNO>
	<brief_summary>The investigator believe iloprost improve gas exchange COPD patient pulmonary hypertension .</brief_summary>
	<brief_title>Iloprost Gas Exchange/Pulm Mechanics Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description>Pulmonary hypertension right heart failure complicate management patient advance COPD . Attempts treat pulmonary hypertension systemic vasodilator frequently result worsen ventilation perfusion match increase sense dyspnea . This study look effect FDA approve pulmonary vasodilator , iloprost , gas exchange pulmonary mechanic patient COPD . Ten clinically stable patient enrol . They report lab morning study arterial line place , pulmonary function measurement arterial blood gas obtain . Iloprost ( 2.5 mcg via nebulizer ) administer effect upon arterial blood pressure , respiration arterial saturation monitor . Pulmonary function test ( PFTs ) blood gas repeat 30 minute . Patients remain clinically stable without evidence fall arterial PO2 systemic blood pressure would inhale second dose 2.5 mcg iloprost . The patient monitor minimum 2 hour last dose iloprost . Primary outcome variable alveolar arterial O2 difference secondary outcome include PAO2 , venous admixture , FVC FEV1 , DLCO ventilatory equivalent O2 CO2 . All comparison make use Student 's t-test Bonferroni correction . The number study patient choose basis power analysis provide alpha 0.05 level 0.9 .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>FEV1 &lt; 65 % predict FEV1 FVC ratio &lt; 70 % Baseline PAO2 stable 6075 mmHg The ability provide inform consent Clinical instability evidence acute exacerbation require intensification therapy and/or need hospitalization precede 3 month . Presence additional cause lung disease suggest history , clinical radiographic finding , pulmonary function test Presence leave ventricular dysfunction and/or leave atrial enlargement echo , ECHO catheterization Heparin allergy Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>chronic obstructive pulmonary disease</keyword>
	<keyword>pulmonary hypertension</keyword>
</DOC>